Table 3.
Number of medical terms in radiology reports.
| Cancer sites | ORRsa, mean medical terms, n (SD; range) | IRRsb, mean medical terms, n (SD; range) | Difference (95% CI)c | P valued | Tukey post hoc test |
| All sites (n=698) | 17.22 (4.01; 9-26) | 4.2 (1; 2-7) | 13.42 (12.72 to 13.32) | <.001 | Significant |
| Brain (n=32) | 14.34 (2.15; 10-18) | 3.5 (0.9; 2-4) | 11.31 (10.76 to 11.83) | <.001 | Significant |
| Thyroid (n=76) | 14.51 (1.35; 12-18) | 3.5 (0.9; 2-5) | 11.34 (10.97 to 11.53) | <.001 | Significant |
| Breast (n=86) | 16.88 (1.99; 14-22) | 4.0 (1.2; 2-6) | 13.17 (12.45to 13.32) | <.001 | Significant |
| Lung (n=98) | 10.26 (0.75; 9-12) | 2.5 (0.6; 2-4) | 8.17 (7.82to 8.84) | <.001 | Significant |
| Esophagus (n=10) | 20.9 (2.42; 18-25) | 5 (1.1; 3-7) | 16.30 (15.04 to 16.76) | <.001 | Significant |
| Gastric (n=30) | 19.80 (1.88; 16-24) | 5 (1.2; 3-6) | 15.23 (14.82 to 15.77) | <.001 | Significant |
| Liver (n=32) | 19.78 (2.11; 15-24) | 4.2 (1; 3-6) | 15.34 (15.14 to 16.42) | <.001 | Significant |
| Pancreas (n=18) | 20 (1.28; 18-22) | 4 (1.1; 3-6) | 15.61 (15.78 to 16.23) | <.001 | Significant |
| Colorectal (n=74) | 21.04 (2.74; 16-25) | 4.1 (1; 2-7) | 16.32 (16.30 to 17.25) | <.001 | Significant |
| Kidney (n=61) | 18.59 (2.49; 12-22) | 4.2 (1.1; 2-6) | 14.33 (14.97 to 15.63) | <.001 | Significant |
| Prostate (n=37) | 18.84 (1.62; 17-22) | 4.1 (1.1; 3-6) | 14.76 (14.72 to 15.52) | <.001 | Significant |
| Bladder (n=50) | 18.72 (1.39; 16-20) | 4.2 (1.1; 2-6) | 14.54 (14.24 to 14.96) | <.001 | Significant |
| Ovary (n=61) | 21.21 (2.42; 16-26) | 4 (1; 2-6) | 16.54 (17.00 to 17.43) | <.001 | Significant |
| Uterus (n=33) | 17.85 (1.75; 16-20) | 4 (1.1; 3-6) | 13.90 (13.97 to 14.57) | <.001 | Significant |
aORR: original radiology report.
bIRR: interpretative radiology report.
cThe 95% CI of the difference between the IRRs and ORRs.
dThe ORRs and IRRs of different cancer sites were analyzed statistically.